Nexstim granted authorization for NBS System 6 in Australia
The TGA approval allows marketing and selling for brain mapping and post-operative motor rehabilitation.
See the latest news and media coverage for Nexstim. We track all announcements, press releases, and industry mentions in real time, all in one place.
Navigated transcranial magnetic stimulation systems provider
nexstim.comLast updated
In short: Nexstim reported 2025 profitability, secured a EUR 5 million investment, and expanded its NBS System 6 presence with new global regulatory approvals.
The TGA approval allows marketing and selling for brain mapping and post-operative motor rehabilitation.
The shares were issued as part of investments from Eiffel and Brainlab, totaling EUR 3.8 million.
He exercised stock options and disposed of derivatives, totaling over 29,000 shares and 29,000 derivatives.
She exercised 6,202 shares and disposed 17,798 derivatives on May 12, 2026.
Nexstim Plc ("Nexstim" or "the Company") has received a notification under Chapter 9, Section 5 of the Securities Markets Act on 15 May 2026. According to the notification, Eiffel Investment Group's holding of Nexstim's shares and votes...
Nexstim Plc (" Nexstim " or " Company ") has received a notification pursuant to chapter 9, section 5 of the Securities Market Act on...
Nexstim Plc ("Nexstim" or the "Company") announces having agreed on an investment with Eiffel Investment Group ("Eiffel"), pursuant to which Eiffel will invest EUR 3.4 million in the Company through a directed share issue ...
Nexstim Plc Business Update Q1 2026 Nexstim Plc ("Nexstim" or "Company") announces the key highlights of the Company's business operations during Q1...
Track Nexstim and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Nexstim and other trending companies.